Efficacy and Safety of Dioxidin Versus Miramistin in Superficial Pyoderma
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
The study is aimed to:
- evaluate the effectiveness of 10-day therapy with Dioxidin® compared with Miramistin® in
the treatment of superficial pyoderma,
- evaluate the safety and tolerability of 10-day therapy with Dioxidin® compared with
Miramistin® for the treatment of superficial pyoderma.